| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3281993 | Clinical Gastroenterology and Hepatology | 2014 | 18 Pages |
Abstract
On the basis of a meta-analysis, bisphosphonate is effective and well tolerated for the treatment of low BMD in patients with IBD and reduces the risk of vertebral fractures. There are insufficient data to support the efficacy of calcium and vitamin D, fluoride, calcitonin, or low-impact exercise. However, the small number of randomized controlled trials limited our meta-analysis.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
John Melek, Atsushi Sakuraba,